St Andrews and Heriot-Watt to collaborate with Stanford University in California
Scottish and US universities are to team up to collaborate on stem cell research into diseases such as Parkinson's.
The universities of St Andrews and Heriot-Watt will collaborate with Stanford University in California to study how stem cells could be used to regenerate tissue damaged as a result of stroke or Parkinson's disease.
Scientists from the three universities will look at how stem cells form and divide to form different types of tissue to treat brain and spinal cord damage.
It marks the second major tie-in between Stanford and Scottish universities.
Stanford already has collaborative agreements in place under the 2009 SU2P agreement with the universities of Strathclyde, St Andrews, Glasgow and Heriot-Watt, which is supported by Research Councils UK (RCUK), the Scottish Funding Council and Scottish Enterprise.
The SU2P industry partnership programme also includes Stanford University and the California Institute of Technology (Caltech).
This latest collaboration was announced as part of First Minister Alex Salmond's trade mission to the United States.
He said: “This research has the potential to lead to incredible medical breakthroughs that could not only give new hope to millions but contribute enormously to the economies of both Scotland and California.”